Literature DB >> 30506034

MicroRNAs and cholangiocarcinoma: elucidating the effects of tiny giants.

Vik Meadows1,2, Heather Francis1,2.   

Abstract

Entities:  

Year:  2018        PMID： 30506034      PMCID： PMC6261289          DOI： 10.21037/amj.2018.09.10

Source DB:  PubMed          Journal:  AME Med J        ISSN： 2520-0518


× No keyword cloud information.
  11 in total

Review 1.  MicroRNAs in cholangiopathies: Potential diagnostic and therapeutic tools.

Authors:  Aitor Esparza-Baquer; Ibone Labiano; Luis Bujanda; María J Perugorria; Jesús M Banales
Journal:  Clin Res Hepatol Gastroenterol       Date:  2016-01-07       Impact factor: 2.947

2.  MicroRNA (miR)-433 and miR-22 dysregulations induce histone-deacetylase-6 overexpression and ciliary loss in cholangiocarcinoma.

Authors:  Adrian P Mansini; Maria J Lorenzo Pisarello; Kristen M Thelen; Maetzin Cruz-Reyes; Estanislao Peixoto; Sujeong Jin; Brynn N Howard; Christy E Trussoni; Gabriella B Gajdos; Nicholas F LaRusso; Maria J Perugorria; Jesus M Banales; Sergio A Gradilone
Journal:  Hepatology       Date:  2018-05-21       Impact factor: 17.425

Review 3.  MicroRNAs and extracellular vesicles in cholangiopathies.

Authors:  P Olaizola; P Y Lee-Law; A Arbelaiz; A Lapitz; M J Perugorria; L Bujanda; J M Banales
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-07-13       Impact factor: 5.187

4.  Targets for human encoded microRNAs in HBV genes.

Authors:  Fang-Li Wu; Wei-Bo Jin; Jia-Hong Li; Ai-Guang Guo
Journal:  Virus Genes       Date:  2010-11-28       Impact factor: 2.332

5.  HDAC6 inhibition restores ciliary expression and decreases tumor growth.

Authors:  Sergio A Gradilone; Brynn N Radtke; Pamela S Bogert; Bing Q Huang; Gabriella B Gajdos; Nicholas F LaRusso
Journal:  Cancer Res       Date:  2013-01-31       Impact factor: 12.701

Review 6.  MicroRNA as Biomarkers and Diagnostics.

Authors:  Jin Wang; Jinyun Chen; Subrata Sen
Journal:  J Cell Physiol       Date:  2016-01       Impact factor: 6.384

7.  Cholangiocarcinoma therapy with nanoparticles that combine downregulation of MicroRNA-210 with inhibition of cancer cell invasiveness.

Authors:  Ying Xie; Yazhe Wang; Jing Li; Yu Hang; Lee Jaramillo; Cody J Wehrkamp; Mary Anne Phillippi; Ashley M Mohr; Yi Chen; Geoffrey A Talmon; Justin L Mott; David Oupický
Journal:  Theranostics       Date:  2018-07-30       Impact factor: 11.556

8.  Epigenetic silencing of tumor suppressor gene CDKN1A by oncogenic long non-coding RNA SNHG1 in cholangiocarcinoma.

Authors:  Yang Yu; Mingjiong Zhang; Ni Wang; Quanpeng Li; Jian Yang; Shuai Yan; Xuezhi He; Guozhong Ji; Lin Miao
Journal:  Cell Death Dis       Date:  2018-07-03       Impact factor: 8.469

9.  MiRNA-29a as a tumor suppressor mediates PRIMA-1Met-induced anti-myeloma activity by targeting c-Myc.

Authors:  Manujendra N Saha; Jahangir Abdi; Yijun Yang; Hong Chang
Journal:  Oncotarget       Date:  2016-02-09

10.  MIR21 Drives Resistance to Heat Shock Protein 90 Inhibition in Cholangiocarcinoma.

Authors:  Andrea Lampis; Pietro Carotenuto; Georgios Vlachogiannis; Luciano Cascione; Somaieh Hedayat; Rosemary Burke; Paul Clarke; Else Bosma; Michele Simbolo; Aldo Scarpa; Sijia Yu; Rebecca Cole; Elizabeth Smyth; Javier Fernández Mateos; Ruwaida Begum; Blanka Hezelova; Zakaria Eltahir; Andrew Wotherspoon; Nicos Fotiadis; Maria Antonietta Bali; Chirag Nepal; Khurum Khan; Mark Stubbs; Jens C Hahne; Pierluigi Gasparini; Vincenza Guzzardo; Carlo M Croce; Suzanne Eccles; Matteo Fassan; David Cunningham; Jesper B Andersen; Paul Workman; Nicola Valeri; Chiara Braconi
Journal:  Gastroenterology       Date:  2017-11-04       Impact factor: 22.682
View more
  1 in total

Review 1.  Inflammation and Progression of Cholangiocarcinoma: Role of Angiogenic and Lymphangiogenic Mechanisms.

Authors:  Sukanya Roy; Shannon Glaser; Sanjukta Chakraborty
Journal:  Front Med (Lausanne)       Date:  2019-12-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.